Skip to content

1 Week Crossover Dispensing Study Between Two Soft Contact Lenses

1 Week Crossover Dispensing Study: Buttermere Versus MiSight 1 Day Soft Contact Lenses

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06170658
Enrollment
30
Registered
2023-12-14
Start date
2023-12-11
Completion date
2024-08-21
Last updated
2025-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myopia

Brief summary

The objective of this investigation is to compare the visual clinical performance of a silicone hydrogel daily disposable investigational contact lenses to a hydrogel daily disposable commercially available contact lenses.

Detailed description

This is a prospective, bilateral, double masked (participant and investigator), randomized, cross-over dispensing study with 1 week wearing period in each arm by comparing visual acuity and subjective vision quality.

Interventions

Daily disposable, silicone hydrogel investigational lenses for one week

Daily disposable, hydrogel commercially available lenses for one week

Sponsors

CooperVision, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
8 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

1. Are 8 to 18 years of age inclusive and have full legal capacity to volunteer; 2. Have read and signed and dated the Parental Permission Form (for those aged 16 and younger); participant has read, signed and dated the study Information Consent Letter (if aged 17 or 18 years) or Assent (aged 16 and younger); 3. Are willing and able to follow instructions and maintain the appointment schedule; 4. Are habitual daily wearers of spherical single vision soft contact lenses to correct for distance vision in each eye; 5. Currently wears spherical soft contact lenses or myopia control soft lenses; 6. Have a pair of wearable back-up spectacles; 7. Are willing and able to wear contact lenses for at least 10 hours a day, 6 days a week while in the study; 8. Are myopic with subjective refraction: -0.75D to -7.00D spherical, with an astigmatism ≤ -0.75D in each eye with maximum spherical equivalent anisometropia of 1.00D 9. Are correctable to a visual acuity of +0.10 logMAR or better (in each eye) with sphero-cylindrical subjective refraction; 10. Have clear corneas with no corneal scars or any active ocular disease; 11. Can be fit with the study contact lenses with a power between -0.75 and -7.00 DS; this translates to best corrected vision sphere refraction that vertexes to a CL power between -0.75 and -7.00 (inclusive) at screening visit. 12. Demonstrate an acceptable fit with the study lenses. 13. Demonstrate that they can safely and independently insert and remove contact lenses at the screening/fitting visit;

Exclusion criteria

1. Have taken part in another clinical research study within the last 14 days; 2. Are currently habitual wearers of toric lenses. 3. Have worn any rigid contact lenses or ortho-keratology lenses in the past 30 days 4. Are an extended lens wearer (i.e., sleeping with their lenses) 5. Are on ongoing atropine treatment for myopia control 6. Have a difference of \> 1.0 D in best vision sphere subjective refraction between eyes; 7. Have amblyopia and/or strabismus/binocular vision problem 8. Have any known active ocular disease, allergies and/or infection; 9. Have a systemic condition that in the opinion of the investigator may affect a study outcome variable; 10. Are using any systemic or topical medications that in the opinion of the investigator may affect a study outcome variable; 11. Have a known sensitivity to the diagnostic pharmaceuticals to be used in the study; 12. Have undergone refractive error surgery or intraocular surgery; 13. Are a member of CORE directly involved in the study.

Design outcomes

Primary

MeasureTime frameDescription
High contrast, binocular, distance visual acuity7 daysDistance visual acuity (LogMAR) will be measured using high and low contrast computer-generated acuity charts.

Secondary

MeasureTime frameDescription
Subjective Vision Quality7 daysSubjective vision quality on 0-100 scale, integer steps (0 = Very poor; 100 = Excellent vision, totally sharp)

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026